Craig A Johnson insider trades

Open-market stock purchases and sales by Craig A Johnson, Director at Aurinia Pharmaceuticals Inc, from SEC Form 4 filings since Jan 4, 2010.

Recent trades

DateStockTradeValue
Jun 4, 2026AUPH Aurinia Pharmaceuticals IncBought (not open market)—
Jan 30, 2026HRTX Heron Therapeutics, Inc /de/Bought (not open market)—
Nov 21, 2025AUPH Aurinia Pharmaceuticals IncSold (not open market)$94.7K

Companies traded

  • AUPH Aurinia Pharmaceuticals Inc: other filings, last Jun 4, 2026
  • HRTX Heron Therapeutics, Inc /de/: 4 sales, last Jan 30, 2026
  • MRTX Mirati Therapeutics, Inc: 7 sales, last Jan 23, 2024
  • LJPC LA Jolla Pharmaceutical Co: other filings, last Aug 22, 2022
  • ODT Odonate Therapeutics, Inc: 1 buy, last Dec 29, 2020
  • ADMP Adamis Pharmaceuticals Corp: other filings, last Oct 16, 2013
  • RDEA Ardea Biosciences, Inc./DE: 3 sales, last Jun 19, 2012
  • NVDL.OB Novadel Pharma Inc: other filings, last Jun 16, 2010

Get free alerts when Craig A Johnson files a new trade →